Hormon Receptor Positive Breast Cancer
2 clinical trials · Condition
◉ Watch Hormon Receptor Positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer (NCT07195227) | MedSIR | 2026-03-24 |
| Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer (NCT01208779) | AstraZeneca | 2011-01-01 |
Track Hormon Receptor Positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.